Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?".
作者信息
Ceccarelli Gabriele, Nardi Katiuscia, Marchesani Francesca
机构信息
Ospedale di Macerata, Division of Dermatology, Via Santa Lucia 2, Macerata, 62100, Italy; Ospedale di Macerata, Division of Medicina COVID, Via Santa Lucia 2, Macerata, 62100, Italy.
Ospedale di Macerata, Division of Medicina COVID, Via Santa Lucia 2, Macerata, 62100, Italy; Ospedale di Macerata, Division of Neurology, Via Santa Lucia 2, Macerata, 62100, Italy.
出版信息
Pharmacol Res. 2020 Aug;158:104933. doi: 10.1016/j.phrs.2020.104933. Epub 2020 May 20.
Abstract
摘要
相似文献
1
Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?".致编辑的信：回应文章《白细胞介素-17能否成为治疗和/或管理新冠病毒相关呼吸综合征的新治疗靶点？》
Pharmacol Res. 2020 Aug;158:104933. doi: 10.1016/j.phrs.2020.104933. Epub 2020 May 20.
2
REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.回复：白细胞介素-17：新冠病毒病的一个潜在治疗靶点。
J Infect. 2020 Sep;81(3):e37-e38. doi: 10.1016/j.jinf.2020.06.063. Epub 2020 Jun 29.
3
Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).对辛格和迪巴尔就文章《COVID-19：从实验室到临床》（辛格等人著）致编辑的信的回复信。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):865. doi: 10.1016/j.dsx.2020.06.012. Epub 2020 Jun 12.
4
Interleukin-17: A potential therapeutic target in COVID-19.白细胞介素-17：新冠病毒病的一个潜在治疗靶点。
J Infect. 2020 Aug;81(2):e136-e138. doi: 10.1016/j.jinf.2020.05.072. Epub 2020 Jun 3.
5
In response to "Role of Telehealth in the Management of COVID-19: Lessons Learned from Previous SARS, MERS, and Ebola Outbreaks".回应《远程医疗在2019冠状病毒病管理中的作用：从既往严重急性呼吸综合征、中东呼吸综合征和埃博拉疫情中吸取的教训》
Telemed J E Health. 2020 Oct;26(10):1209-1210. doi: 10.1089/tmj.2020.0141. Epub 2020 May 29.
6
Letter to the Editor: Is Coronavirus Disease 2019 A Real Threat to the Nervous System?致编辑的信：2019冠状病毒病对神经系统构成真正威胁吗？
World Neurosurg. 2020 Nov;143:631. doi: 10.1016/j.wneu.2020.08.094.
7
Letter to the editor. Concerning the article entitled ''Guillain Barre syndrome associated with COVID-19 infection: A case report".致编辑的信。关于题为“COVID-19 感染相关格林-巴利综合征：一例报告”的文章。
J Clin Neurosci. 2020 Sep;79:257-258. doi: 10.1016/j.jocn.2020.06.025. Epub 2020 Jul 4.
8
In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".致编辑的信的回复，主题为“冠状病毒病（COVID-19）的神经学影响：神经科学界的实际考量” 。
World Neurosurg. 2020 Oct;142:535-536. doi: 10.1016/j.wneu.2020.06.115. Epub 2020 Jun 23.
9
Letter to the editor-Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis.致编辑的信——严重急性呼吸综合征、中东呼吸综合征和新型冠状病毒肺炎感染中急性肾损伤的死亡率：一项系统评价和荟萃分析
Crit Care. 2020 Sep 11;24(1):555. doi: 10.1186/s13054-020-03239-0.
10
Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists".致编辑的信：“作为内分泌学家和糖尿病专家，我们对COVID-19的应对措施”
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa224.
引用本文的文献
1
Natural history of COVID-19 and current knowledge on treatment therapeutic options.COVID-19 的自然史和当前治疗选择的治疗知识。
Biomed Pharmacother. 2020 Sep;129:110493. doi: 10.1016/j.biopha.2020.110493. Epub 2020 Jul 3.
本文引用的文献
1
COVID-19 diagnosis and management: a comprehensive review.COVID-19 的诊断与管理：全面综述。
J Intern Med. 2020 Aug;288(2):192-206. doi: 10.1111/joim.13091. Epub 2020 May 13.
2
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.新型冠状病毒病 2019（COVID-19）的患病率和严重程度：系统评价和荟萃分析。
J Clin Virol. 2020 Jun;127:104371. doi: 10.1016/j.jcv.2020.104371. Epub 2020 Apr 14.
3
Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?白细胞介素-17能否成为治疗和/或管理新型冠状病毒肺炎相关呼吸综合征的新治疗靶点？
Pharmacol Res. 2020 Jun;156:104791. doi: 10.1016/j.phrs.2020.104791. Epub 2020 Apr 14.
4
On the Alert for Cytokine Storm: Immunopathology in COVID-19.警惕细胞因子风暴：COVID-19 的免疫病理学。
Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. doi: 10.1002/art.41285. Epub 2020 May 10.
5
Tocilizumab treatment in COVID-19: A single center experience.托珠单抗治疗 COVID-19：单中心经验。
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
6
Dual roles of calpain in facilitating Coxsackievirus B3 replication and prompting inflammation in acute myocarditis.钙蛋白酶在促进柯萨奇病毒B3复制及引发急性心肌炎炎症中的双重作用
Int J Cardiol. 2016 Oct 15;221:1123-31. doi: 10.1016/j.ijcard.2016.07.121. Epub 2016 Jul 9.
Zotero 插件